NCT01574170 2026-04-17
METAL3
Institut Claudius Regaud
Phase 4 Completed
Clinical Trials
12 trialsNCT06427811 2026-04-17
ASC4INDIA
Novartis
Phase 4 Completed
NCT01127295 2026-04-14
PHACS
Institut Claudius Regaud
Phase 4 Completed
NCT01553903 2026-04-14
OXYTAM
Institut Claudius Regaud
Phase 4 Completed
NCT01612871 2026-04-14
MIRHO
Institut Claudius Regaud
Phase 4 Completed
NCT03514381 2026-04-14
IPIAP-STM
Institut Claudius Regaud
Phase 4 Completed
NCT05651282 2026-04-13
RESToRE
University of British Columbia
Phase 4 Completed
NCT05110196 2026-04-07
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
Phase 4 Completed
NCT05365230 2026-04-07
A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer
Ottawa Hospital Research Institute
Phase 4 Completed
NCT05631795 2026-04-07
ALPINIST
Novartis
Phase 4 Completed
NCT02555748 2026-03-31
SUP-R
Institut Claudius Regaud
Phase 4 Completed
NCT04266665 2026-03-25
Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome
Aristotle University Of Thessaloniki
Phase 4 Completed